Literature DB >> 17712842

Reliability and validity of ICARS in focal cerebellar lesions.

Beate Schoch1, Jens Peter Regel, Markus Frings, Marcus Gerwig, Matthias Maschke, Markus Neuhäuser, Dagmar Timmann.   

Abstract

To evaluate the therapies for cerebellar diseases appropriate neurological assessment methods to measure severity of ataxia are required. Reliability and validity of the semiquantitative International Cooperative Ataxia Rating Scale (ICARS) has recently been examined in patients with degenerative ataxias. We evaluated reliability (internal consistency), criterion-related validity and internal construct validity of ICARS for the first time in patients with focal cerebellar lesions (68 patients with surgical lesions and 68 patients with ischemic lesions). For comparison 45 patients with degenerative cerebellar ataxia were included. We found an excellent Cronbach's alpha as a measurement for internal consistency which was independent from underlying disease. Criterion-related validity was high. Total ICARS score mirrored clearly the immediate postsurgical worsening and the improvement during the first 3 months after focal surgical and ischemic lesions, whereas in chronic state of focal and degenerative cerebellar disorders ICARS score remained nearly unchanged. Principal component analysis in patients with focal lesions revealed five distinct and clinically meaningful factors which corresponded to the four ICARS subscores and reflected the laterality of kinetic functions. In degenerative disorders, however, the items for the subscore "kinetic function" loaded to more than one factor. Total ICARS score seems to be a useful and valid measurement to describe the time course of ataxia in patients with focal and degenerative disorders affecting primarily the cerebellum. Validity of subscores however is good in focal, but not in degenerative disorders. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Year:  2007        PMID: 17712842     DOI: 10.1002/mds.21543

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS.

Authors:  Jeremy D Schmahmann; Raquel Gardner; Jason MacMore; Mark G Vangel
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

2.  Prognostic Importance of Lesion Location on Functional Outcome in Patients with Cerebellar Ischemic Stroke: a Prospective Pilot Study.

Authors:  Alessandro Picelli; Paola Zuccher; Giampaolo Tomelleri; Paolo Bovi; Giuseppe Moretto; Andreas Waldner; Leopold Saltuari; Nicola Smania
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

3.  Longitudinal tracking of gait and balance impairments in cerebellar disease.

Authors:  Susanne M Morton; Ya-Weng Tseng; Kathleen M Zackowski; Jaclyn R Daline; Amy J Bastian
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

4.  Long-term sequelae after acquired pediatric hemorrhagic cerebellar lesions.

Authors:  Kevin Wingeier; Sandra Bigi; Marwan El-Koussy; Theda Heinks-Maldonado; Eugen Boltshauser; Maja Steinlin
Journal:  Childs Nerv Syst       Date:  2010-12-29       Impact factor: 1.475

5.  DTI fiber tractography of cerebro-cerebellar pathways and clinical evaluation of ataxia in childhood posterior fossa tumor survivors.

Authors:  Myung Eun Oh; Pablo Hernáiz Driever; Rajiv K Khajuria; Stefan Mark Rueckriegel; Elisabeth Koustenis; Harald Bruhn; Ulrich-Wilhelm Thomale
Journal:  J Neurooncol       Date:  2016-10-26       Impact factor: 4.130

6.  Ataxia Rating Scales Reveal Increased Scores in Very Preterm Born 5-6-Year-Old Preschool Children and Young Adults.

Authors:  Bilge Albayrak; Anne-Kathrin Dathe; Katharina Maria Heuser-Spura; Ursula Felderhoff-Mueser; Dagmar Timmann; Britta Maria Huening
Journal:  Cerebellum       Date:  2022-08-26       Impact factor: 3.648

7.  Effects of Two Exercise Regimes on Patients with Chiari Malformation Type 1: a Randomized Controlled Trial.

Authors:  Ceyhun Türkmen; Nezire Köse; Ercan Bal; Sevil Bilgin; Hatice Çetin; Hatice Yağmur Zengin; Ekim Gümeler; Melike Mut
Journal:  Cerebellum       Date:  2022-03-24       Impact factor: 3.847

8.  Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial.

Authors:  Luciana Chessa; Vincenzo Leuzzi; Alessandro Plebani; Annarosa Soresina; Roberto Micheli; Daniela D'Agnano; Tullia Venturi; Anna Molinaro; Elisa Fazzi; Mirella Marini; Pierino Ferremi Leali; Isabella Quinti; Filomena Monica Cavaliere; Gabriella Girelli; Maria Cristina Pietrogrande; Andrea Finocchi; Stefano Tabolli; Damiano Abeni; Mauro Magnani
Journal:  Orphanet J Rare Dis       Date:  2014-01-09       Impact factor: 4.123

9.  Storage of a naturally acquired conditioned response is impaired in patients with cerebellar degeneration.

Authors:  Andreas Thieme; Markus Thürling; Julia Galuba; Roxana G Burciu; Sophia Göricke; Andreas Beck; Volker Aurich; Elke Wondzinski; Mario Siebler; Marcus Gerwig; Vlastislav Bracha; Dagmar Timmann
Journal:  Brain       Date:  2013-05-31       Impact factor: 13.501

Review 10.  Motor training in degenerative spinocerebellar disease: ataxia-specific improvements by intensive physiotherapy and exergames.

Authors:  Matthis Synofzik; Winfried Ilg
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.